๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus

โœ Scribed by Dr. Stephen D. Ryder; Dr. John Koskinas; Paolo M. Rizzi; Ian G. McFarlane; Bernard C. Portmann; Nikolai V. Naoumov; Roger Williams


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
540 KB
Volume
22
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


The risk of hepatocellular carcinoma in autoimmune hepatitis is low, even in patients with long-standing cirrhosis. Because of the increasing recognition of an association of hepatitis C virus (HCV) with autoimmune hepatitis, at least in some geographical areas, and with hepatocellular carcinoma (HCC) (hepatoma), we have examined eight cases (4 male, 4 female) who presented between 1985 and 1993 with hepatoma complicating autoimmune hepatitis. All had steroid-responsive autoimmune hepatitis with serum anti-smooth muscle and antinuclear autoantibodies. Median duration of disease was 17.1 years, and all patients had biopsy-proven cirrhosis. One patient had a history of intravenous drug abuse, and four had previously received blood transfusions. Serum samples (stored at -20ยฐC from up to 9 years before diagnosis of hepatoma) were tested for anti-hepatitis C virus antibodies by a second-third-generation assay and for HCV RNA by the polymerase chain reaction method using primers from the B'noncoding region. Tissue from liver adjacent to tumor areas was subjected to polymerase chain reaction along with tissue from previous liver biopsy specimens (taken up to 19 years before diagnosis of hepatoma) in all patients. Six patients had evidence of HCV infection: four seropositive for HCV RNA (two of whom were also anti-HCV positive) and two seronegative for HCV RNA and anti-HCV but with HCV RNA in liver tissue at presentation with hepatoma. Retrospective testing showed probable acquisition of HCV through blood transfusion in the four transfused patients. The findings suggest that HCV may have oncogenic potential and that hepatoma complicating autoim-Abbreviations: IICV, hepatitis C virus; AIH. autoimmune hepatitis; IICC,


๐Ÿ“œ SIMILAR VOLUMES


Does hepatitis C virus cause hepatocellu
โœ Hubert E. Blum ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 592 KB

Most of you are aware that Dr. Jorge Gumucio has completed his tenure as editor of the HEPATOLOGY Elsewhere section. During his stewardship it has become a thoroughly enjoyable section for many of us to peruse. Not only are we able to keep in pace with all the developments in liver disease that are

Hepatitis C virus antibody in hepatocell
โœ Jen-Eing Jeng; Jung-Fa Tsai ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 426 KB ๐Ÿ‘ 1 views

The prevalence of antibody to hepatitis C virus (anti-HCV) was investigated in patients with hepatocellular carcinoma (HCC), and correlated with the clinical features. Anti-HCV was detected in 129 histology or aspiration cytology proven HCC patients and 54 healthy controls. Anti-HCV was examined by